Clinical Trial Update: Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing insulin glargine as a first-line therapy to metformin in type 2 diabetes has completed, with the registry status shown as COM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• metformin (metformin)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED